Educational video made available by the Southern Medical Association. Please support our mission to Improve quality of health care through education by joining or making a contribution to our research and education fund.

Join - http://sma.org/join
Donate - http://sma.org/donate

Dr. Michael Atkins, medical oncologist, talks about how patients are benefiting from the latest research in melanoma and answers the most commonly asked questions about the disease. Click "Show More" to see the list of questions and links to specific questions.

Learn more about Dr. Atkins: http://ow.ly/LIgKU

Learn more about the new therapies for melanoma at MedStar Georgetown: http://ow.ly/M48ho

Learn more about -
Melanoma: http://ow.ly/Rt3LX
Melanoma Treatment: http://ow.ly/Rt3OA

0:00-3:12 meet Dr. Michael Atkins meet Dr. Michael Atkins
3:12 What is melanoma?
3:54 Why did I get melanoma?
5:17 What other forms of skin cancer exist besides melanoma?
5:42 What is the risk of my melanoma spreading or coming back?
7:53 How does melanoma recur? Is it a new spot on the skin?
8:50 My CT scan shows no sign of melanoma. Does that mean it hasn’t spread to distant sites?
9:55 How can you detect melanoma recurrence early?
11:18 What can I do to keep my melanoma from coming back?
12:08 How have melanoma treatments progressed in recent years?
16:45 What are the characteristics of a melanoma on the skin?
17:47 If I have a mole that’s changing what should I do?
18:32 What is metastatic melanoma?
19:36 Can melanoma happen without a mole or mark on my skin?
20:33 Is metastatic melanoma curable?
21:26 How do you treat metastatic melanoma?
23:38 What are the side effects of melanoma treatments?
25:50 Are these melanoma treatments covered by insurance?
27:02 If the medications are not covered by insurance can they be covered by the research study?
27:36 Why should I come to MedStar Georgetown University Hospital for the treatment of melanoma?
29:04 What different doctors will I see for melanoma treatment?
29:50 What is the role of research and how you’re treating melanoma now?

Webinar Recording: “Melanoma and Non-Melanoma Skin Cancers From A-Z” with Dermatologist Thomas G. Salopek, MD FRCPC, Professor, Department of Medicine, Division of Dermatology, University of Alberta.

This webinar helps educate the general public about the dangers of UV exposure, and it also addresses what options patients and their families have if they are diagnosed with any form of skin cancer. Learn about skin cancer statistics in Canada, sun protection and safety, and details on treatment for primary and metastatic basal cell carcinoma, squamous cell carcinoma, merkel cell carcinoma, and melanoma and melanoma sub-types. For more detailed information on immunotherapy and targeted therapy for each of these please view our webinars on each, at https://saveyourskin.ca/webinars-video-resources/
This webinar presentation is in collaboration with Save Your Skin Foundation, La Roche-Posay, the Quebec Cancer Foundation, and the Alberta Society of Melanoma.

To learn more about treatment options for melanoma, please copy and paste this link into your browser to see another of our past webinars detailing immunotherapy and targeted therapy: https://youtu.be/nS9OAFgknwE

To learn all about the NCCN Patient Guidelines to which Dr. Salopek referred, please copy and paste this link into your browser: https://saveyourskin.ca/nccn-g....uidelines-for-skin-c

For questions or more information on anything presented here please email natalie@saveyourskin.ca or reach Kathy at 1-800-460-5832.
For more information visit https://saveyourskin.ca/

Malignant tumors or cancers are classified based on their embryonic origin, tissues of origin, types of cells involved.

PLEASE SUBSCRIBE THE CHANNEL 🙏😍

CANCER
https://youtu.be/-2QYB_cKJ38
CLASSIFICATION OF CANCER
https://youtu.be/msqFmCtnw2Y
THE DEVELOPMENT OF CANCER
https://youtu.be/142Duv7Uh90
CAUSES OF CANCERS | PART 1
https://youtu.be/kRSnQ0AlDUI
CAUSES OF CANCER; HORMONES, VIRUSES, CHEMICALS | PART 2
https://youtu.be/UMBEvQJEU34
TUMOR VIRUSES | PART 1
https://youtu.be/qP3DgbInEKM
TUMOR VIRUSES | PART2
https://youtu.be/8ivjvdhUeuo
ONCOGENE | PROTO-ONCOGENE | CANCER INDUCTION
https://youtu.be/e7q5wq809rk
TUMORS OF THE IMMUNE SYSTEM
https://youtu.be/i92gu94ZwDA
TUMOR SUPPRESSOR GENE, ANTI-ONCOGENE OR ONCOSUPPRESSOR GENE
https://youtu.be/7xk4GqPUzqE
TUMOR ANTIGENS
https://youtu.be/_FW-omn_LyE
APOPTOSIS | PROGRAMMED CELL DEATH
https://youtu.be/wVpS-IdxFGc

Reference
https://amzn.to/3Nd2ech
https://amzn.to/3IHjmTU
https://amzn.to/3LfPpw6
https://amzn.to/3Nd3OuJ
https://amzn.to/3iQkcn3
https://amzn.to/36ma1nA
https://amzn.to/3wHGU8G
https://amzn.to/3NjhOmr


#agaricusmalayalam #cancer #classificationofcancer #carcinomas #sarcomas #leukemias #lymphomas.

Presented at Cancer Research & Oncology 2017

Federico Monzon, MD - Chief Medical Officer at Castle Biosciences, Baylor College of Medicine

Dr. Monzon is a molecular pathologist with extensive experience translating novel genomic technologies into clinical molecular tests. Most recently, he served as Medical Director of Oncology and Medical Director of Latin America at Invitae Corporation, a provider of genetic diagnostics for hereditary disorders. Previously, Dr. Monzon served in several successive roles at Baylor College of Medicine, including Director of Pathology at its Cancer Genetics Laboratory. Earlier in his career, he led studies at the University of Pittsburgh on prostate and renal cancer genomics as well as the validation of one of the first gene expression clinical assays for the diagnosis of tumors of unknown origin. He earned his M.D. from the Universidad Nacional Autónoma de México, and is board-certified by the American Board of Pathology in anatomic, clinical and molecular genetic pathology. Dr. Monzon is the 2016 President-Elect of the Association for Molecular Pathology.

Personalizing Melanoma Management with Molecular Diagnostics

More and more decisions will center on the ability to molecularly characterize a disease. So the molecular diagnostic laboratory will have a pivotal role. What does that look like? Will we be able to maintain an environment where we have academic laboratories doing a good chunk of innovation and development that then can get translated into either reference laboratories or tests being done at local laboratories within the academic core and even community hospitals? The ecosystem that exists now encourages innovation to happen quickly and get those tests quickly into the hands of the clinical laboratories and make them accessible to patients. So the question is can we maintain this ecosystem when we overlay regulatory pressures, and financial or reimbursement pressures.

Earn PACE/CME Credits:
1. Make sure you’re a registered member of LabRoots: https://www.labroots.com/virtu....al-event/cancer-rese
2. Watch the webinar on YouTube above or on the LabRoots Website : https://www.labroots.com/virtu....al-event/cancer-rese
3. Click Here to get your PACE - October 11, 2019 – http://www.labroots.com/credit..../pace-credits/2553/t

LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc